Cargando…

Machine Learning Applied to Patient‐Reported Outcomes to Classify Physician‐Derived Measures of Rheumatoid Arthritis Disease Activity

OBJECTIVE: Patient‐reported outcome (PRO) data have assumed increasing importance in the care of patients with rheumatoid arthritis (RA), yet physician‐derived disease activity measures, such as Clinical Disease Activity Index (CDAI), remain the most accepted metrics to assess disease activity. The...

Descripción completa

Detalles Bibliográficos
Autores principales:	Curtis, Jeffrey R., Su, Yujie, Black, Shawn, Xu, Stephen, Langholff, Wayne, Bingham, Clifton O., Kafka, Shelly, Xie, Fenglong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wiley Periodicals, Inc. 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9746663/ https://www.ncbi.nlm.nih.gov/pubmed/36220128 http://dx.doi.org/10.1002/acr2.11499

Ejemplares similares

Response to Treatment with Intravenous Golimumab or Infliximab in Rheumatoid Arthritis Patients: PROMIS Results from the Real-World Observational Phase 4 AWARE Study
por: Bingham, Clifton O., et al.
Publicado: (2023)

Incidence of Infusion Reactions and Clinical Effectiveness of Intravenous Golimumab Versus Infliximab in Patients with Rheumatoid Arthritis: The Real-World AWARE Study
por: Curtis, Jeffrey R., et al.
Publicado: (2021)

Machine Learning Approaches to Classify Self-Reported Rheumatoid Arthritis Health Scores Using Activity Tracker Data: Longitudinal Observational Study
por: Rao, Kaushal, et al.
Publicado: (2023)

Effectiveness and safety of intravenous golimumab with and without concomitant methotrexate in patients with rheumatoid arthritis in the prospective, noninterventional AWARE study
por: Broadwell, Aaron, et al.
Publicado: (2023)

The Economic Benefit of Remission for Patients with Rheumatoid Arthritis
por: Curtis, Jeffrey R., et al.
Publicado: (2022)

Serious infections in patients with self-reported psoriatic arthritis from the Psoriasis Longitudinal Assessment and Registry (PSOLAR) treated with biologics
por: Ritchlin, Christopher T., et al.
Publicado: (2019)

Will savings from biosimilars offset increased costs related to dose escalation? A comparison of infliximab and golimumab for rheumatoid arthritis
por: Curtis, Jeffrey R., et al.
Publicado: (2019)

Use of ICD-10 diagnosis codes to identify seropositive and seronegative rheumatoid arthritis when lab results are not available
por: Curtis, Jeffrey R., et al.
Publicado: (2020)

Antibody response to pneumococcal and influenza vaccination in patients with rheumatoid arthritis receiving abatacept
por: Alten, Rieke, et al.
Publicado: (2016)

Demography, baseline disease characteristics, and treatment history of psoriasis patients with self-reported psoriatic arthritis enrolled in the PSOLAR registry
por: Kavanaugh, Arthur, et al.
Publicado: (2018)

PROMIS Fatigue short forms are reliable and valid in adults with rheumatoid arthritis
por: Bingham III, Clifton O., et al.
Publicado: (2019)

Comparing cardiovascular risk of patients with rheumatoid arthritis within the Social Security Disability Insurance with those commercially insured
por: Navarro-Millán, Iris, et al.
Publicado: (2022)

The effect of tofacitinib on residual pain in patients with rheumatoid arthritis and psoriatic arthritis
por: Dougados, Maxime, et al.
Publicado: (2022)

Factors associated with physicians’ prescriptions for rheumatoid arthritis drugs not filled by patients
por: Kan, Hong J., et al.
Publicado: (2018)

Enhanced reactivity to pain in patients with rheumatoid arthritis
por: Edwards, Robert R, et al.
Publicado: (2009)

Identification of biomarkers by machine learning classifiers to assist diagnose rheumatoid arthritis-associated interstitial lung disease
por: Qin, Yan, et al.
Publicado: (2022)

BAFF inhibition does not significantly impair immunization responses in patients with rheumatoid arthritis
por: Bingham, Clifton O., et al.
Publicado: (2015)

Treatment goals for rheumatoid arthritis: patient engagement and goal collection
por: Predmore, Zachary, et al.
Publicado: (2023)

The challenges in classifying rheumatoid arthritis-associated interstitial lung disease
por: Nurmi, Hanna, et al.
Publicado: (2020)

Smoking is not linked to the development of anti-peptidylarginine deiminase 4 autoantibodies in rheumatoid arthritis
por: Cappelli, Laura C., et al.
Publicado: (2018)

Reliability and Validity of Selected PROMIS Measures in People with Rheumatoid Arthritis
por: Bartlett, Susan J., et al.
Publicado: (2015)

Biologic Disease-Modifying Antirheumatic Drug Prescription Patterns for Rheumatoid Arthritis Among United States Physicians
por: Sullivan, Emma, et al.
Publicado: (2020)

Assessing physician and patient acceptance of infliximab biosimilars in rheumatoid arthritis, ankylosing spondyloarthritis and psoriatic arthritis across Germany
por: Waller, John, et al.
Publicado: (2017)

The effect of tofacitinib on pneumococcal and influenza vaccine responses in rheumatoid arthritis
por: Winthrop, Kevin L, et al.
Publicado: (2016)

Participant Engagement and Adherence to Providing Smartwatch and Patient-Reported Outcome Data: Digital Tracking of Rheumatoid Arthritis Longitudinally (DIGITAL) Real-World Study
por: Nowell, William B, et al.
Publicado: (2023)

Efficacy and safety of intravenous golimumab plus methotrexate in patients with rheumatoid arthritis aged < 65 years and those ≥ 65 years of age
por: Tesser, John, et al.
Publicado: (2019)

Humoral immune response to vaccines in patients with rheumatoid arthritis treated with tocilizumab: results of a randomised controlled trial (VISARA)
por: Bingham, Clifton O, et al.
Publicado: (2015)

Derivation and internal validation of a multi-biomarker-based cardiovascular disease risk prediction score for rheumatoid arthritis patients
por: Curtis, Jeffrey R., et al.
Publicado: (2020)

Applying machine classifiers to update searches: Analysis from two case studies
por: Stansfield, Claire, et al.
Publicado: (2021)

The specialist physician’s approach to rheumatoid arthritis in South Africa
por: Bester, Frederik C. J., et al.
Publicado: (2016)

Soluble Markers of Antibody Secreting Cell Function as Predictors of Infection Risk in Rheumatoid Arthritis
por: Gutierrez, Maria J., et al.
Publicado: (2019)

Myocardial citrullination in rheumatoid arthritis: a correlative histopathologic study
por: Giles, Jon T, et al.
Publicado: (2012)

Data‐Driven Patient Clustering and Differential Clinical Outcomes in the Brigham and Women’s Rheumatoid Arthritis Sequential Study Registry
por: Curtis, Jeffrey R., et al.
Publicado: (2021)

Geographic Variation in Disease Burden and Mismatch in Care of Patients With Rheumatoid Arthritis in the United States
por: Dowell, Sharon, et al.
Publicado: (2023)

Views of primary care physicians and rheumatologists regarding screening and treatment of hyperlipidemia among patients with rheumatoid arthritis
por: Navarro-Millán, Iris, et al.
Publicado: (2020)

Autoantibodies to Peptidylarginine Deiminase 2 Are Associated With Less Severe Disease in Rheumatoid Arthritis
por: Darrah, Erika, et al.
Publicado: (2018)

Applying science in practice: the optimization of biological therapy in rheumatoid arthritis
por: Ramiro, Sofia, et al.
Publicado: (2010)

Applying refinement to the use of mice and rats in rheumatoid arthritis research
por: Hawkins, Penny, et al.
Publicado: (2015)

Profiling of Gene Expression Biomarkers as a Classifier of Methotrexate Nonresponse in Patients With Rheumatoid Arthritis
por: Plant, Darren, et al.
Publicado: (2019)

Citrullination modulates antigen processing and presentation by revealing cryptic epitopes in rheumatoid arthritis
por: Curran, Ashley M., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_s2ahuhbv0lp4sb1sqqkh039deb